Intraoperative guidance in parathyroid surgery using near-infrared fluorescence imaging and low-dose Methylene Blue
- PMID: 25958068
- PMCID: PMC4603995
- DOI: 10.1016/j.surg.2015.03.027
Intraoperative guidance in parathyroid surgery using near-infrared fluorescence imaging and low-dose Methylene Blue
Abstract
Background: Identification of diseased and normal parathyroid glands during parathyroid surgery can be challenging. The aim of this study was to assess whether near-infrared (NIR) fluorescence imaging using administration of a low-dose Methylene Blue (MB) at the start of the operation could provide optical guidance during parathyroid surgery and assist in the detection of parathyroid adenomas.
Methods: Patients diagnosed with primary hyperparathyroidism planned for parathyroidectomy were included. Patients received 0.5 mg/kg MB intravenously directly after start of anesthesia. During the operation, NIR fluorescence imaging was performed to identify parathyroid adenomas. Imaging results were compared with a previous published feasibility study in which 12 patients received MB after intraoperative identification of the adenoma.
Results: A total of 13 patients were included in the current study. In 10 of 12 patients with a histologically proven adenoma, the adenoma was fluorescent. Mean signal to background ratio was 3.1 ± 2.8. Mean diameter of the resected lesions was 17 ± 9 mm (range 5-28 mm). Adenomas could be identified up to 145 minutes after administration, which was the longest timespan until resection. Interestingly, in 3 patients, a total of 6 normal parathyroid glands (median diameter 2.5 mm) with a signal to background ratio of 1.8 ± 0.4 were identified using NIR fluorescence imaging.
Conclusion: Early administration of low-dose MB provided guidance during parathyroidectomy by identifying both parathyroid adenomas and normal parathyroid glands. In patients in whom difficult identification of the parathyroid adenoma is expected or when normal glands have to be identified, the administration of MB may improve surgical outcome.
Copyright © 2015 Elsevier Inc. All rights reserved.
Conflict of interest statement
Quirijn R.J.G. Tummers, M.D.: Nothing to declare
Abbey Schepers, M.D., Ph.D.: Nothing to declare
Jaap F. Hamming, M.D., Ph.D.: Nothing to declare
J. Kievit, M.D., Ph.D.: Nothing to declare
John V. Frangioni, M.D., Ph.D.: FLARE™ technology is owned by Beth Israel Deaconess Medical Center, a teaching hospital of Harvard Medical School. Dr. Frangioni has started three for-profit companies, Curadel, Curadel ResVet Imaging, and Curadel Surgical Innovations, which has optioned FLARE™ technology for potential licensing from Beth Israel Deaconess Medical Center.
Cornelis J.H. van de Velde, M.D., Ph.D.: Nothing to declare
Alexander L. Vahrmeijer, M.D., Ph.D.: Nothing to declare
Figures


Similar articles
-
Intraoperative near-infrared fluorescence imaging of parathyroid adenomas with use of low-dose methylene blue.Head Neck. 2014 Jun;36(6):853-8. doi: 10.1002/hed.23384. Epub 2013 Oct 4. Head Neck. 2014. PMID: 23720199 Free PMC article.
-
Use of methylene blue and near-infrared fluorescence in thyroid and parathyroid surgery.Langenbecks Arch Surg. 2018 Feb;403(1):111-118. doi: 10.1007/s00423-017-1641-2. Epub 2017 Dec 11. Langenbecks Arch Surg. 2018. PMID: 29230539 Free PMC article. Clinical Trial.
-
Thoracoscopic resection with intraoperative use of methylene blue to localize mediastinal parathyroid adenomas.Gen Thorac Cardiovasc Surg. 2012 Mar;60(3):168-70. doi: 10.1007/s11748-011-0796-y. Epub 2012 Mar 15. Gen Thorac Cardiovasc Surg. 2012. PMID: 22419188
-
Imaging of parathyroid glands.Otolaryngol Clin North Am. 2010 Apr;43(2):399-415, x. doi: 10.1016/j.otc.2010.01.008. Otolaryngol Clin North Am. 2010. PMID: 20510723 Review.
-
Surgery for primary hyperparathyroidism.Cancer. 2014 Dec 1;120(23):3602-16. doi: 10.1002/cncr.28891. Epub 2014 Jul 9. Cancer. 2014. PMID: 25042934 Review.
Cited by
-
Optical coherence tomography for thyroid pathology: 3D analysis of tissue microstructure.Biomed Opt Express. 2020 Jul 9;11(8):4130-4149. doi: 10.1364/BOE.394296. eCollection 2020 Aug 1. Biomed Opt Express. 2020. PMID: 32923033 Free PMC article.
-
Methylene Blue-Based Near-Infrared Fluorescence Imaging for Breast Cancer Visualization in Resected Human Tissues.Technol Cancer Res Treat. 2019 Jan-Dec;18:1533033819894331. doi: 10.1177/1533033819894331. Technol Cancer Res Treat. 2019. PMID: 31835962 Free PMC article.
-
Non-Small Cell Lung Cancer Imaging Using a Phospholipase A2 Activatable Fluorophore.Chem Biomed Imaging. 2024 Jun 20;2(7):490-500. doi: 10.1021/cbmi.4c00026. eCollection 2024 Jul 22. Chem Biomed Imaging. 2024. PMID: 39056064 Free PMC article.
-
Preclinical evaluation of molecularly targeted fluorescent probes in perfused amputated human limbs.J Biomed Opt. 2023 Aug;28(8):082802. doi: 10.1117/1.JBO.28.8.082802. Epub 2023 Jan 5. J Biomed Opt. 2023. PMID: 36619496 Free PMC article.
-
Intraoperative Identification of the Parathyroid Gland with a Fluorescence Detection System.World J Surg. 2017 Jun;41(6):1506-1512. doi: 10.1007/s00268-017-3903-0. World J Surg. 2017. PMID: 28168320
References
-
- Fraser WD. Hyperparathyroidism. Lancet. 2009 Jul 11;374(9684):145–58. - PubMed
-
- Phillips CD, Shatzkes DR. Imaging of the parathyroid glands. Semin Ultrasound CT MR. 2012 Apr;33(2):123–9. - PubMed
-
- Han N, Bumpous JM, Goldstein RE, Fleming MM, Flynn MB. Intra-operative parathyroid identification using methylene blue in parathyroid surgery. Am Surg. 2007 Aug;73(8):820–3. - PubMed
-
- Harrison BJ, Triponez F. Intraoperative adjuncts in surgery for primary hyperparathyroidism. Langenbecks Arch Surg. 2009 Sep;394(5):799–809. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous